Tor Shwayder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tor Shwayder has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Ben J. Friedman
Department of Dermatology, Henry Ford Hospital, Detroit, MI
4 shared publications - Allison Zarbo
Department of Dermatology Henry Ford Health System Detroit Michigan USA
3 shared publications Devika Patel
3 shared publications- Devika Patel
Department of Psychology, Stony Brook University, Stony Brook, NY 11794, USA
3 shared publications Rattanavalai Chantorn
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3 shared publicationsAllison Zarbo
Department of Dermatology, Henry Ford Health System, Detroit, MI, USA
2 shared publications
Latest Publications
- 26 February 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (3) , 558-559
Unresectable infantile myofibroma discovered in utero
The authors present a case of a proliferative nodule located beneath an infant's lower lip that was initially discovered on prenatal ultrasound and fetal magnetic resonance imaging (MRI). Biopsy revealed a smooth muscle actin-positive spindled cell proliferation with hemangiopericytoma-like vessels consistent with infantile myofibromatosis (IM). Since the location prevented surgical management, the clinicians opted to observe the lesion. Ultimately, the lesion fully regressed on its own confirming conservative management is an option for isolated IM.
- 26 February 2024
- Published by Wiley in Pediatric Dermatology
- Vol. 41 (3) , 558-559
Unresectable infantile myofibroma discovered in utero
The authors present a case of a proliferative nodule located beneath an infant's lower lip that was initially discovered on prenatal ultrasound and fetal magnetic resonance imaging (MRI). Biopsy revealed a smooth muscle actin-positive spindled cell proliferation with hemangiopericytoma-like vessels consistent with infantile myofibromatosis (IM). Since the location prevented surgical management, the clinicians opted to observe the lesion. Ultimately, the lesion fully regressed on its own confirming conservative management is an option for isolated IM.
- Open Access
- 23 June 2022
- Published by Wiley in Pediatric Dermatology
- Vol. 39 (6) , 992-994
Microcystic lymphatic malformation presenting as firm, skin‐colored papules of the lips
Microcystic lymphatic malformation (MiLM), also known as lymphangioma circumscriptum, is a superficial collection of lymphatic vessels measuring <1 cm in the largest diameter, often with a more extensive deeper malformation. It commonly presents as discrete or grouped plaques of clear or hemorrhagic vesicles classically described as "frogspawn"; however, here we describe a case of its unique presentation as firm papules on the lips of a healthy six-year-old child. These skin-colored papules in the absence of vesicles with lymphatic and/or hemorrhagic fluid may not be clinically indicative of MiLM. This case represents a diagnostic challenge due to the unique morphology of pink, fleshy papules as opposed to the clear or hemorrhagic vesicles typically observed in MiLM.
- 23 June 2022
- Published by Wiley in Pediatric Dermatology
- Vol. 39 (6) , 992-994
Open AccessMicrocystic lymphatic malformation presenting as firm, skin‐colored papules of the lips
Microcystic lymphatic malformation (MiLM), also known as lymphangioma circumscriptum, is a superficial collection of lymphatic vessels measuring <1 cm in the largest diameter, often with a more extensive deeper malformation. It commonly presents as discrete or grouped plaques of clear or hemorrhagic vesicles classically described as "frogspawn"; however, here we describe a case of its unique presentation as firm papules on the lips of a healthy six-year-old child. These skin-colored papules in the absence of vesicles with lymphatic and/or hemorrhagic fluid may not be clinically indicative of MiLM. This case represents a diagnostic challenge due to the unique morphology of pink, fleshy papules as opposed to the clear or hemorrhagic vesicles typically observed in MiLM.
- 1 November 2021
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (6) , e45-e47
An erythematous patch on the ear and face of a young boy
- 1 November 2021
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (6) , e45-e47
An erythematous patch on the ear and face of a young boy
- 1 November 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (6) , 1145-1146
Congenital midline nodules on the chin and sternum
- 1 November 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (6) , 1145-1146
Congenital midline nodules on the chin and sternum
- 15 May 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , 767-768
Melanoma arising in a patient with ataxia‐telangiectasia: A call for full skin examinations in this patient population
Ataxia‐telangiectasia (A‐T) is an autosomal recessive, multisystem disorder characterized by cerebellar ataxia and oculocutaneous telangiectasias that present in early childhood. Increased incidence of malignancy is also associated with A‐T. Hematopoietic malignancies occur most commonly, with a majority being lymphoid cancers; however, there is a risk for other malignancies, such as breast, gastric, and other solid tumors. Herein, we report the case of a 28‐year‐old woman with A‐T with melanoma.
- 15 May 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , 767-768
Melanoma arising in a patient with ataxia‐telangiectasia: A call for full skin examinations in this patient population
Ataxia‐telangiectasia (A‐T) is an autosomal recessive, multisystem disorder characterized by cerebellar ataxia and oculocutaneous telangiectasias that present in early childhood. Increased incidence of malignancy is also associated with A‐T. Hematopoietic malignancies occur most commonly, with a majority being lymphoid cancers; however, there is a risk for other malignancies, such as breast, gastric, and other solid tumors. Herein, we report the case of a 28‐year‐old woman with A‐T with melanoma.
- Open Access
- 1 February 2020
- Published by Elsevier in JAAD Case Reports
- Vol. 6 (2) , 92-95
A girl with loose anagen hair syndrome and concurrent uncombable hair syndrome
- 1 February 2020
- Published by Elsevier in JAAD Case Reports
- Vol. 6 (2) , 92-95
Open AccessA girl with loose anagen hair syndrome and concurrent uncombable hair syndrome
- 2 October 2019
- Published by Springer Nature
- p. 23-53
Pediatrics
- 27 February 2019
- Published by Wiley in Pediatric Dermatology
- Vol. 36 (3) , 339-341
ABCA12 homozygous mutation in harlequin ichthyosis: Survival without systemic retinoids
Harlequin ichthyosis (HI) is associated with high mortality. Early systemic retinoids are widely used, although their use remains debatable. We reported two neonates with homozygous mutations in ABCA12 consistent with harlequin ichthyosis who survived to discharge home with intensive care and without use of systemic retinoids.
- 27 February 2019
- Published by Wiley in Pediatric Dermatology
- Vol. 36 (3) , 339-341
ABCA12 homozygous mutation in harlequin ichthyosis: Survival without systemic retinoids
Harlequin ichthyosis (HI) is associated with high mortality. Early systemic retinoids are widely used, although their use remains debatable. We reported two neonates with homozygous mutations in ABCA12 consistent with harlequin ichthyosis who survived to discharge home with intensive care and without use of systemic retinoids.
- 28 August 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (6) , E366-E367
Poikiloderma with neutropenia and associated squamous cell carcinoma: A case report
Here, we describe a case of a patient with known poikiloderma with neutropenia who developed cutaneous squamous cell carcinoma in a chronically sun‐exposed area at the age of 14. To date, there is only one other report of this association. This report highlights the need for routine skin cancer screening in patients with this diagnosis as well as the importance of a correct initial diagnosis.
- 28 August 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (6) , E366-E367
Poikiloderma with neutropenia and associated squamous cell carcinoma: A case report
Here, we describe a case of a patient with known poikiloderma with neutropenia who developed cutaneous squamous cell carcinoma in a chronically sun‐exposed area at the age of 14. To date, there is only one other report of this association. This report highlights the need for routine skin cancer screening in patients with this diagnosis as well as the importance of a correct initial diagnosis.
- 28 June 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (5) , 566-574
Cutaneous manifestations of metastatic Crohn's disease
Metastatic Crohn's disease is a rare cutaneous complication of primary Crohn's disease. It is a granulomatous inflammatory process, similar to the pathogenic mechanism of Crohn's disease, that occurs in sites discontiguous from the gastrointestinal tract. Metastatic Crohn's disease can precede the development of Crohn's disease by months to years, and children are more likely to present with metastatic Crohn's disease in the absence of gastrointestinal symptoms. Given that approximately 30% of individuals with Crohn's disease present in childhood, early recognition of extraintestinal manifestations of Crohn's disease such as metastatic Crohn's disease can aid in timely diagnosis and management of bowel disease. We present data from two pediatric cases of metastatic Crohn's disease recently seen at our institution in addition to the 61 reported cases of pediatric metastatic Crohn's disease in the literature. This review article will focus on the epidemiology, pathogenesis, clinical features, and histology of and treatment options for pediatric metastatic Crohn's disease.
- 28 June 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (5) , 566-574
Cutaneous manifestations of metastatic Crohn's disease
Metastatic Crohn's disease is a rare cutaneous complication of primary Crohn's disease. It is a granulomatous inflammatory process, similar to the pathogenic mechanism of Crohn's disease, that occurs in sites discontiguous from the gastrointestinal tract. Metastatic Crohn's disease can precede the development of Crohn's disease by months to years, and children are more likely to present with metastatic Crohn's disease in the absence of gastrointestinal symptoms. Given that approximately 30% of individuals with Crohn's disease present in childhood, early recognition of extraintestinal manifestations of Crohn's disease such as metastatic Crohn's disease can aid in timely diagnosis and management of bowel disease. We present data from two pediatric cases of metastatic Crohn's disease recently seen at our institution in addition to the 61 reported cases of pediatric metastatic Crohn's disease in the literature. This review article will focus on the epidemiology, pathogenesis, clinical features, and histology of and treatment options for pediatric metastatic Crohn's disease.